Rectal sparing and dysplasia risk in PSC-IBD
What is the evidence that rectal sparing in PSC‑IBD predicts a lower risk of colorectal dysplasia compared with continuous pancolitis
What is known
- In a single-center retrospective cohort, no PSC-IBD patients who underwent subtotal colectomy for rectal-sparing disease (n=26) developed dysplasia or neoplasia in the residual colon or rectum. 1
- Among PSC-IBD patients who had IPAA (n=99), pouch/rectal-cuff dysplasia or neoplasia was low (about 1%–2%), and the LGD cases had been operated on for rectal-sparing refractory disease. 1
- PSC-IBD carries a broadly elevated colorectal cancer/dysplasia risk (roughly threefold or higher versus IBD alone), independent of the surgical-outcome data. 2,3
What is unknown / caveats
- Single retrospective referral-center cohort with small subtotal-colectomy subgroup (n=26); no direct rectal-sparing vs pancolitis dysplasia comparison
- Favorable outcomes were conditional on adequate endoscopic surveillance being implemented
- Subclinical/right-sided inflammation in PSC-IBD is commonly underestimated, and IBD duration may be underestimated
- Whether the rectal-sparing phenotype is intrinsically protective, or whether the low observed neoplasia simply reflects removal of colon plus ongoing surveillance, cannot be separated from these data.
References
- Dunleavy KA, Santiago P, Forde G, Harmsen WS, McKenna NP, Coelho-Prabhu N, Shawki S, Raffals L. Total Proctocolectomy vs Subtotal/total Colectomy for Neoplasia in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Inflamm Bowel Dis. 2024;30:1935-1945. PMID: 38142126.
- de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015;21(6):1956-71. PMID: 25684965.
- Ricciuto A, Kamath BM, Griffiths AM. The IBD and PSC Phenotypes of PSC-IBD. Curr Gastroenterol Rep. 2018;20(4):16. PMID: 29594739.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
⚠ Required context not in this corpus (severe). UC with PSC carries a substantially increased risk of colorectal dysplasia/carcinoma versus UC alone, OR 4.79 (95% CI 3.58-6.41) (Soetikno 2002 meta-analysis, PMID 12085034).
Why this matters: A clinician told only that a single cohort found no excess CRC could conclude risk is not elevated in UC-PSC and de-intensify dysplasia surveillance in the highest-risk colitis population, risking interval cancer.
Added by the landmark interlock. This corpus is surgical in scope and cannot admit the source paper (PMID 12085034). Not generated by the RAG.
⚠ Required context not in this corpus (moderate). SCENIC consensus (Laine 2015, PMID 25708752): dysplasia surveillance in colonic IBD uses high-definition colonoscopy with chromoendoscopy and TARGETED biopsy of visible lesions, and a completely endoscopically resected visible dysplastic lesion is followed by surveillance rather than reflex colectomy.
Why this matters: Advising colectomy for an endoscopically resectable visible dysplastic lesion, or describing random-biopsy-only surveillance as current practice, can commit a patient to an avoidable proctocolectomy.
Added by the landmark interlock. This corpus is surgical in scope and cannot admit the source paper (PMID 25708752). Not generated by the RAG.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
Reviewer notes